2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 15.947 | 17.514 | 26.924 | 26.638 | 25.999 | 30.526 | 15.278 | 16.941 | 21.114 | 21.795 |
Total Income - EUR | 19.151 | 18.788 | 26.924 | 26.638 | 25.999 | 31.247 | 20.373 | 18.387 | 23.136 | 22.746 |
Total Expenses - EUR | 20.768 | 20.868 | 22.417 | 26.055 | 24.987 | 31.492 | 18.719 | 13.705 | 15.808 | 18.147 |
Gross Profit/Loss - EUR | -1.617 | -2.081 | 4.507 | 583 | 1.012 | -245 | 1.653 | 4.682 | 7.328 | 4.599 |
Net Profit/Loss - EUR | -2.208 | -2.606 | 4.238 | 318 | 751 | -558 | 1.512 | 4.514 | 7.096 | 4.372 |
Employees | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 2 | 1 | 2 |
Check the financial reports for the company - Impuls Asimed S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 3.615 | 2.449 | 1.238 | 193 | 514 | 282 | 59 | 0 | 0 | 455 |
Current Assets | 4.663 | 3.240 | 2.510 | 2.666 | 3.465 | 3.478 | 6.753 | 9.289 | 14.943 | 18.890 |
Inventories | 1.965 | 932 | 1.123 | 1.087 | 1.010 | 1.192 | 3.101 | 2.148 | 939 | 677 |
Receivables | 170 | 97 | 96 | 709 | 92 | 330 | 2.243 | 1.326 | 934 | 1.084 |
Cash | 2.528 | 2.211 | 1.291 | 869 | 2.363 | 1.957 | 1.409 | 5.815 | 13.069 | 17.129 |
Shareholders Funds | -1.705 | -4.325 | -44 | 275 | 1.021 | 444 | 1.948 | 6.419 | 13.535 | 17.866 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 9.983 | 10.015 | 3.791 | 2.584 | 2.958 | 3.316 | 4.863 | 2.871 | 1.408 | 1.479 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "9602 - 9602" | |||||||||
CAEN Financial Year |
9602
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Impuls Asimed S.r.l.